Trials / Sponsors / SynCore Biotechnology Co., Ltd.
SynCore Biotechnology Co., Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRIN Metastatic Pancreas Cancer, Locally Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma | Phase 3 | 2018-10-16 |
| Terminated | To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer Head and Neck Neoplasms | Phase 2 | 2017-04-30 |
| Suspended | A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compar Triple-Negative Breast Cancer | Phase 3 | 2016-11-23 |
| Terminated | Study of SCB01A in Patient With Head and Neck Cancer Head and Neck Squamous Cell Carcinoma | Phase 2 | 2015-09-01 |
| Completed | A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy Solid Tumors | Phase 1 | 2011-04-01 |
| No Longer Available | Long-Term Compassionate Use Study for Continued Administration of SCB01A-01 Malignant Solid Tumour | — | — |